|
Step 1: Misoprostol – treatment doses
|
|
Received at least 1 procurement of misoprostol treatment doses
|
72.8 (55.5, 91.2)
|
75.3 (52.1, 89.5)
|
P = .78
|
|
Experienced stock out within the last 12 months
|
24.7 (9.4, 50.8)
|
53.4 (33.1, 72.6)
|
P = .06
|
|
Stock-out levels within last 12 months
|
|
Never
|
75.3 (49.2, 90.6)
|
47.2 (27.7, 67.7)
|
P = .07
|
|
Less than 1 month
|
5.4 (1.5, 17.2)
|
26.6 (12.0, 49.2)
|
|
1–3 months
|
10.4 (2.6, 33.1)
|
26.1 (10.6, 51.3)
|
|
Over 3 months
|
8.9 (1.2, 44.1)
|
0
|
|
Expired stock at time of data collection
|
25.2 (11.9, 45.9)
|
49.8 (33.3, 66.4)
|
P = .05
|
|
Step 2: Uterine balloon tamponade kits
|
|
Received at least 1 procurement of UBT kits
|
80 (61.5, 91.0)
|
80 (57.0, 92.0)
|
p = .63
|
|
Experienced stock-out within the last 12 months
|
0.3 (0, 2.7)
|
23.4 (10.1, 45.4)
|
p < .001
|
|
Stock-out levels within last 12 months
|
|
Never
|
99.7 (97.3, 100)
|
81.8 (59.4, 93.2)
|
p = .001
|
|
Less than 1 month
|
0
|
2.1 (0.4, 9.3)
|
|
1–3 months
|
0.3 (0, 2.7)
|
16.1 (5.3, 39.9)
|
|
Over 3 months
|
0
|
0
|
|
Incomplete UBT kits in stock
|
9.6 (3.8, 22.3)
|
60.1 (41.2, 76.4)
|
p < .001
|
|
Step 3: Non-pneumatic anti-shock garment
|
|
Functional NASG in stock
|
87.9 (63.3, 96.4)
|
91.5 (66.7, 98.3)
|
p = .62
|
|
Quantity of NASG in stock
|
|
None
|
12.1 (3.6, 33.7)
|
8.5 (1.7, 33.3)
|
p = .62
|
|
1–3
|
87.5 (66.3, 96.1)
|
91.1 (67.2, 98.1)
|
|
4+
|
0.4 (0.2, 1.1)
|
0.4 (0.2, 1.0)
|
